14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Oct 10, 2022 $51.85 $51.88 $51.83 $51.85 463 686
Oct 07, 2022 $51.83 $51.88 $51.82 $51.86 715 873
Oct 06, 2022 $51.84 $51.87 $51.83 $51.85 756 806
Oct 05, 2022 $51.82 $51.90 $51.78 $51.89 723 022
Oct 04, 2022 $51.84 $51.89 $51.80 $51.87 945 475
Oct 03, 2022 $51.70 $51.88 $51.66 $51.82 1 250 698
Sep 30, 2022 $51.67 $51.79 $51.66 $51.66 1 046 898
Sep 29, 2022 $51.68 $51.74 $51.60 $51.66 1 837 068
Sep 28, 2022 $51.65 $51.76 $51.64 $51.68 1 325 234
Sep 27, 2022 $51.65 $51.77 $51.60 $51.64 927 790
Sep 26, 2022 $51.63 $51.76 $51.61 $51.62 1 351 664
Sep 23, 2022 $51.76 $51.80 $51.55 $51.64 4 972 865
Sep 22, 2022 $51.78 $51.80 $51.76 $51.78 853 189
Sep 21, 2022 $51.78 $51.84 $51.75 $51.80 1 090 847
Sep 20, 2022 $51.80 $51.85 $51.78 $51.80 1 188 505
Sep 19, 2022 $51.54 $51.63 $51.53 $51.56 937 016
Sep 16, 2022 $51.60 $51.62 $51.22 $51.55 3 190 726
Sep 15, 2022 $51.61 $51.71 $51.55 $51.60 1 201 916
Sep 14, 2022 $51.42 $51.53 $51.35 $51.53 1 121 864
Sep 13, 2022 $51.47 $51.58 $51.36 $51.37 1 320 928
Sep 12, 2022 $51.47 $51.55 $51.40 $51.50 1 080 503
Sep 09, 2022 $51.54 $51.60 $51.47 $51.49 662 421
Sep 08, 2022 $51.42 $51.66 $51.39 $51.60 954 207
Sep 07, 2022 $51.43 $51.50 $51.36 $51.50 1 400 843
Sep 06, 2022 $51.40 $51.56 $51.30 $51.48 1 760 823
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT